Pyxis Oncology

PYXSNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$279.834 M

$3.36 +5.17%

Close of 22 Sept 2026

Revenue

$13.9M

#3085 by revenue

Earnings

-$79.6M

Loss-making

Shares outstanding

83,408,050

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#240AmarinAMRN$290.4M
#241Greenwich LifeSciencesGLSI$285.9M
#242Pyxis OncologyPYXS$279.8M
#243AC ImmuneACIU$277.8M
#244Lyell ImmunopharmaLYEL$273.2M

What if Pyxis Oncology were worth as much as…

Open the what-if tool →

Gold $30.2T

$362,482.63

Per share 108,043× higher

Bitcoin $1.74T

$20,881.14

Per share 6,224× higher

Nvidia $5.52T

$66,129.91

Per share 19,711× higher

Or at a round number

$500.0M $1.00B $2.00B $5.00B

Where these numbers come from

Share counts and financials for Pyxis Oncology are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 23 Sept 2026. Read the methodology.